by In2Pharma | Aug 23, 2024 | News
Europe The Commission Regulation (EU) 2024/2041, dated 29 July 2024, which amends Regulation (EU) No 432/2012 concerning the health claim for monacolin K from red yeast rice, was published in the Official Journal on 30 July. The European Commission’s regulation...
by In2Pharma | Jun 24, 2024 | News
Belgium Since September 22, 2022, a law was published that put into force that companies who don’t use German text on food supplement packs, can be sanctioned. The compulsory use of German for selling in the German-speaking community immediately entered into force....
by In2Pharma | May 10, 2023 | News
Belgium The Mixed Committee of the FAMHP (which examines the ‘grey zone’ products) has issued a new guideline regarding the use of D-mannose in food supplements. Products with an amount of D-mannose higher than 750 mg/day can have a significant...
by In2Pharma | May 14, 2019 | News
The Netherlands In the Netherlands, the court has ruled on a case in which a medical search term led to a Google Ad for a food supplement. The court decided that this is unacceptable publicity for medicines. The Google Ad for the food supplement appeared after typing...
by In2Pharma | Mar 13, 2019 | News
Belgium As from March 30, 2019, the United Kingdom (UK) will no longer be a member of the European Union (EU). Although to date, no agreement between the EU and the UK has been approved, the companies involved in Brexit should anticipate the consequences as much as...
